CIK: 0001964437 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 13, 2025
Total Value ($000): $246,761 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JAZZ | JAZZ PHARMACEUTICALS PLC | 206,952 | $21,962 | 8.9% | $108.63 | 0.0% | SHS USD | G50871105 |
| IRON | DISC MEDICINE INC | 396,115 | $20,978 | 8.5% | $47.97 | -2.1% | COM | 254604101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 3,260,570 | $20,900 | 8.5% | $4.21 | +15.7% | COM | 03237H101 |
| PCVX | VAXCYTE INC | 544,221 | $17,693 | 7.2% | $48.83 | -32.9% | COM | 92243G108 |
| COGT | COGENT BIOSCIENCES INC | 2,297,524 | $16,496 | 6.7% | $7.59 | -27.0% | COM | 19240Q201 |
| CELC | CELCUITY INC | 1,185,520 | $15,827 | 6.4% | $15.84 | -31.3% | COM | 15102K100 |
| CGON | CG ONCOLOGY INC | 586,647 | $15,253 | 6.2% | $34.79 | -30.7% | COM | 156944100 |
| XENE | XENON PHARMACEUTICALS INC | 468,364 | $14,660 | 5.9% | $39.67 | -17.8% | COM | 98420N105 |
| DYN | DYNE THERAPEUTICS INC | 1,455,429 | $13,856 | 5.6% | $11.01 | 0.0% | COM | 26818M108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 290,784 | $13,725 | 5.6% | $47.43 | -14.1% | CLASS A ORD | 61559X104 |
| — | MERUS N V | 224,260 | $11,796 | 4.8% | $35.99 | — | COM | N5749R100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 793,327 | $10,424 | 4.2% | $13.84 | — | SPONSORED ADS | 152309100 |
| LENZ | LENZ THERAPEUTICS INC | 342,312 | $10,033 | 4.1% | $27.20 | 0.0% | COM | 52635N103 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 58,181 | $7,313 | 3.0% | $114.68 | 0.0% | COM | 64125C109 |
| OCUL | OCULAR THERAPEUTIX INC | 728,576 | $6,761 | 2.7% | $8.25 | -5.2% | COM | 67576A100 |
| ASND | ASCENDIS PHARMA A/S | 38,191 | $6,592 | 2.7% | $128.89 | — | SPONSORED ADR | 04351P101 |
| ARGX | ARGENX SE | 10,285 | $5,669 | 2.3% | $394.09 | — | SPONSORED ADR | 04016X101 |
| ABVX | ABIVAX SA | 622,479 | $4,762 | 1.9% | $13.48 | — | SPONSORED ADS | 00370M103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 500,551 | $4,688 | 1.9% | $18.17 | -39.4% | COM | 87164F105 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 220,695 | $3,997 | 1.6% | $19.89 | -8.3% | ORDINARY SHARES | N62509109 |
| CTNM | CONTINEUM THERAPEUTICS INC | 319,348 | $1,268 | 0.5% | $15.90 | -72.7% | CL A | 21217B100 |
| REPL | REPLIMUNE GROUP INC | 128,917 | $1,198 | 0.5% | $8.73 | 0.0% | COM | 76029N106 |
| KALV | KALVISTA PHARMACEUTICALS INC | 62,793 | $710 | 0.3% | $7.51 | +62.7% | COM | 483497103 |
| SLN | SILENCE THERAPEUTICS PLC | 34,737 | $201 | 0.1% | $11.10 | — | ADS | 82686Q101 |